1. Home
  2. NMRA vs JMSB Comparison

NMRA vs JMSB Comparison

Compare NMRA & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • JMSB
  • Stock Information
  • Founded
  • NMRA 2019
  • JMSB 2005
  • Country
  • NMRA United States
  • JMSB United States
  • Employees
  • NMRA N/A
  • JMSB N/A
  • Industry
  • NMRA
  • JMSB Major Banks
  • Sector
  • NMRA
  • JMSB Finance
  • Exchange
  • NMRA Nasdaq
  • JMSB Nasdaq
  • Market Cap
  • NMRA 287.6M
  • JMSB 268.9M
  • IPO Year
  • NMRA 2023
  • JMSB N/A
  • Fundamental
  • Price
  • NMRA $1.28
  • JMSB $17.21
  • Analyst Decision
  • NMRA Buy
  • JMSB
  • Analyst Count
  • NMRA 8
  • JMSB 0
  • Target Price
  • NMRA $10.14
  • JMSB N/A
  • AVG Volume (30 Days)
  • NMRA 1.3M
  • JMSB 19.1K
  • Earning Date
  • NMRA 03-03-2025
  • JMSB 04-24-2025
  • Dividend Yield
  • NMRA N/A
  • JMSB 1.45%
  • EPS Growth
  • NMRA N/A
  • JMSB 233.33
  • EPS
  • NMRA N/A
  • JMSB 1.20
  • Revenue
  • NMRA N/A
  • JMSB $53,688,000.00
  • Revenue This Year
  • NMRA N/A
  • JMSB N/A
  • Revenue Next Year
  • NMRA N/A
  • JMSB N/A
  • P/E Ratio
  • NMRA N/A
  • JMSB $14.34
  • Revenue Growth
  • NMRA N/A
  • JMSB 38.39
  • 52 Week Low
  • NMRA $1.26
  • JMSB $15.00
  • 52 Week High
  • NMRA $17.19
  • JMSB $26.52
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 26.96
  • JMSB 37.65
  • Support Level
  • NMRA $1.26
  • JMSB $16.87
  • Resistance Level
  • NMRA $1.48
  • JMSB $17.53
  • Average True Range (ATR)
  • NMRA 0.13
  • JMSB 0.57
  • MACD
  • NMRA 0.08
  • JMSB -0.06
  • Stochastic Oscillator
  • NMRA 4.44
  • JMSB 23.95

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc provides banking services. The company offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

Share on Social Networks: